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Abstract
Background: Universal screening of children for dyslipidemia and other cardiovascular risk factors has been
recommended. Given the clustering of cardiovascular risk factors within families, one benefit of screening
adolescents may be to identify “at-risk” families in which adult members might also be at elevated risk and
potentially benefit from medical evaluation.
Methods: Cross-sectional study of grade 9 students evaluating adiposity, lipids and blood pressure. Data collected
by Heart Niagara Inc. through the Healthy Heart Schools’ Program. Parents completed questionnaires, evaluating
family history of dyslipidemia, hypertension, diabetes and early cardiovascular disease events in parents and siblings
(first-degree relatives), and grandparents (second-degree relatives). Associations between positive risk factor findings
in adolescents and presence of a positive family history were assessed in logistic regression models.
Results: N = 4014 adolescents ages 14–15 years were screened; 3467 (86 %) provided family medical history.
Amongst adolescents, 4.7 % had dyslipidemia, 9.5 % had obesity, and 3.5 % had elevated blood pressure. Central
adiposity (waist-to-height ratio ≥0.5) in the adolescent was associated with increased odds of diabetes in first-
(OR:2.0 (1.6–2.6), p < 0.001) and second-degree relatives (OR:1.3 (1.1–1.6), p = 0.002). Dyslipidemia was associated
with increased odds of diabetes (OR:1.6 (1.1–2.3), p < 0.001), hypertension (OR:2.2 (1.5–3.2), p < 0.001) and
dyslipidemia (OR:2.2 (1.5–3.2),p < 0.001) in first degree relatives. Elevated blood pressure did not identify increased
odds of a positive family history.
Conclusions: Presence of obesity and/or dyslipidemia in adolescents identified through a universal school-based
screening program is associated with risk factor clustering within families. Universal pediatric cardiometabolic
screening may be an effective entry into reverse cascade screening.
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Background
Landmark autopsy studies have shown that, in children
who died accidentally, there was an exponential increase
in the extent of their atherosclerotic burden as the number
of cardiovascular risk factors increased [1–4]. Many of
these risk factors are modifiable, such as obesity, dyslipid-
emia, hypertension, and abnormal glucose metabolism in-
cluding increased insulin resistance and diabetes. It has
been well established that the presence of these risk factors
in childhood increases the incidence of cardiometabolic
disease in adulthood [5–7]. In addition, cardiovascular risk
factors often cluster within members of families, with both
genetic and common environmental/behavioral determi-
nants [8, 9].
Amongst adults, those between 18 and 44 years old have
the lowest health-care utilization [10], creating the poten-
tial for delayed identification and management of cardio-
metabolic risk factors and disease. Children, however,
typically receive continuous medical care, and recent
integrated guidelines have recommended universal lipid
screening of pre-pubertal children [11]. Therefore, screen-
ing children for dyslipidemia and other cardiovascular risk
factors may serve as an entry point to identifying at-risk
family members. We sought to evaluate the association
between pediatric cardiometabolic risk factors identified
through universal school-based cardiometabolic screening
and the presence of elevated cardiometabolic risk factors
and cardiovascular disease (CVD) in family members.
Methods
We conducted a population-based cross-sectional study
of grade 9 students (14–15 years old) in the Niagara Re-
gion of Ontario, Canada during the 2009–2010 school
year. The study was undertaken in co-operation with
Heart Niagara Inc. Healthy Heart Schools’ Program. This
curriculum enrichment program is designed to provide
personalized education regarding cardiometabolic risk
and healthy lifestyle behaviours, as well as individualized
testing, to students in a classroom setting. The program
annually targets the entire grade 9 population through
their mandatory physical education class (the last school
grade where such a mandate exists) in the geographically
and administratively defined Niagara Region, Ontario.
No students were excluded from participating in the
screening. During the 2009–2010 school year, 4104
students participated. All parents of students were pro-
vided with questionnaires (described below). Data ana-
lysis included all participants who had participated in the
screening and had completed the questionnaires. Adoles-
cents presenting with adverse cardiovascular risk profiles
were referred back to their primary care provider, where
the whole family is encouraged to undergo screening,
thus potentially providing a reverse cascade screening
tool. The detailed methods of the Healthy Heart Schools’
Program have been previously described [12]. Adoles-
cents provided informed assent and parents/guardians
provided written consent to participate in the assessment;
the consent included a statement that the participant’s dei-
dentified data may be used for research purposes. Formal
ethics approval was obtained by Heart Niagara, Inc. from
the research ethics committees of both the Niagara Cath-
olic District School Board and the District School Board of
Niagara. The Hospital for Sick Children investigators were
approved by Heart Niagara, Inc. for secondary use of
deidentified data through a negotiated data-sharing agree-
ment between Heart Niagara, Inc. and The Hospital for
Sick Children.
Data collection
Heart Niagara Inc. staff performed all physical measure-
ments during a scheduled assessment day during usual
class time. Height and weight measurements were ob-
tained in a standardized manner. Body mass index (BMI)
was calculated (weight in kilograms divided by height in
meters squared) and age- and sex-specific percentiles
and z scores were determined using the 2006 World
Health Organization growth standards [13]. Overweight
was defined as a BMI between the 85th and less than the
95th percentile, and obesity was defined as a BMI greater
than or equal to the 95th percentile [13]. Waist circum-
ference was measured in a standardized manner, with
land marking at the top of the posterior iliac crest with
the subject standing. The waist-to-height ratio (WHtR,
waist circumference divided by height) was calculated
and classified into 3 categories: <0.5, 0.5–< 0.6, and ≥0.6.
Previous studies have suggested that a WHtR above 0.5
may be an effective indicator of increased cardiometa-
bolic risk [14–16]. The two remaining categories were
based on the methodology of previous studies [17, 18].
Finger stick capillary samples were used to obtain non-
fasting levels of total cholesterol (TC) and high-density lipo-
protein cholesterol (HDL-C). From this, non-high-density
lipoprotein cholesterol was calculated (non-HDL-C, TC
minus HDL-C).
Blood pressure was evaluated in a standardized manner
as previously described [12]. Systolic and diastolic mea-
surements were converted to age-, sex-, and height-
specific percentiles [19]. These values were used to classify
the subjects as normotensive (<90th percentile), prehyper-
tensive (90th–< 95th percentile), stage 1 hypertensive
(95th–< 99th percentile), or stage 2 hypertensive (≥99th
percentile) [19]. If initial measurements were at or above
the 95th percentile, the measurements were repeated. If
the second measurement was less than the 95th percentile,
that value was used and no further blood pressure mea-
surements were performed. However, if the second meas-
urement was at or above the 95th percentile, 6 automated
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readings were taken at 1-min intervals and the average
was calculated.
Students were provided with a questionnaire aimed at
reporting whether first degree (siblings and parents) and
second-degree relatives (grandparents) had a medical
history of dyslipidemia, hypertension, diabetes mellitus,
and a history of premature CVD. Premature CVD was
defined as any male relative with a heart attack or stroke
before 55 years and any female relative before 65 years
[12]. The questionnaires were completed at home by the
students with help from their parents (for family history
questions) and submitted prior to the assessment day.
Data analysis
Data were analyzed and displayed as means with standard
deviations and frequencies, as appropriate. Odds ratios
with confidence intervals were used to assess associations
between identified cardiometabolic risk factor in adoles-
cents and a positive family history for cardiometabolic risk
or early CVD. Only subjects with all completed measure-
ments and a completed questionnaire were included in
the analysis. Statistical analyses were performed using SAS
statistical software version 9.3 (The SAS Institute, Cary
NC).
Results
Enrollment in the school program for the study period
was 4104 adolescents, of which 3467 (85 % of all regis-
tered grade 9 students, 50 % male, average age 14.6 ±
0.5 years) adolescents had family history data available.
Table 1 shows the descriptive data for the grade 9 partic-
ipants. Significant differences between male and female
students were noted with BMI classification and lipid
values. Family history data are shown in Table 2.
Forest plots depicting the odds ratios with confidence
intervals for a positive family history of diabetes, dyslip-
idemia, elevated blood pressure, and/or premature CVD
in first and second degree family members (based on
parental reporting) for a given identified cardiometabolic
risk factor in the adolescents are shown in Fig. 1. Adoles-
cents with increased adiposity (BMI ≥95th percentile or
WHtR ≥0.5) had increased odds of having a first- or
second-degree family member with diabetes. WHtR
showed greater odds ratios than BMI. Adolescents with
Table 1 Characteristics of the study population
Variable Number Male Female p
3467 1718 (50 %) 1749 (50 %)
BMI classification (World Health Organization) 3382 0.002
Underweight (<5th percentile) 36 (2 %) 32 (2 %)
Normal weight (≥5th–<85th percentile) 1042 (62 %) 1157 (68 %)
Overweight (≥85th–<95th percentile) 251 (15 %) 239 (14 %)
Obese (≥95th percentile) 349 (21 %) 276 (16 %)
Waist-to-height ratio 3382 0.24
<0.5 1324 (79 %) 1379 (81 %)
0.5–< 0.6 281 (17 %) 266 (16 %)
≥0.6 73 (4 %) 59 (3 %)
Elevated blood pressure (maximum systolic/diastolic blood pressure) 3359
Normal (<90th percentile) 1526 (91 %) 1544 (91 %) 0.46
Pre-hypertension (90–< 95th percentile) 76 (5 %) 91 (5 %)
Stage 1 hypertension (95th–< 99th percentile) 52 (3 %) 44 (3 %)
Stage 2 hypertension (≥99th percentile) 15 (1 %) 11 (1 %)
Total cholesterol classification 3061 <0.001
Normal (<4.4 mmol/L) 1282 (84 %) 1122 (73 %)
Borderline high (4.4–< 5.2 mmol/L) 191 (13 %) 323 (21 %)
High (≥5.2 mmol/L) 50 (3 %) 93 (6 %)
Low high-density lipoprotein (HDL-C) (<1.03 mmol/L) 3005 572 (38 %) 279 (18 %) <0.001
Non-high density lipoprotein (non-HDL-C) classification 3061 0.001
Normal 1224 (80 %) 1149 (75 %)
Borderline high (≥3.10 to <3.75 mmol/L) 196 (13 %) 268 (17 %)
High (≥3.75 mmol/L) 103 (7 %) 121 (8 %)
P values correspond to differences between males and females regarding classification distribution or prevalence of abnormalities
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an elevated TC had increased odds of having a first-
degree family member with diabetes, dyslipidemia or
hypertension. Adolescents with an elevated non-HDL-C
had increased odds of having a first-degree family mem-
ber with diabetes, dyslipidemia, or hypertension, and a
second-degree family member with diabetes. Adoles-
cents with elevated blood pressure did not have in-
creased odds of having a family member with a positive
family history. None of the measured cardiometabolic
risk factors in adolescents were significantly associated
with increased odds of having a positive family history
of premature CVD.
Discussion
The findings of our study indicate that cardiometabolic
risk factors identified through universal school-based
screening of adolescents is associated with the presence
of risk factors in family members. The presence of
dyslipidemia was associated with a positive family his-
tory of diabetes, dyslipidemia, and hypertension while
the presence of increased adiposity was associated with a
positive family history of diabetes. Adolescents with in-
creased blood pressure measurements did not have in-
creased odds of having family members with increased
cardiometabolic risk factors. It should be noted that the
elevated blood pressure measurements identified in a
universal screening setting are not indicative of a diag-
nosis of hypertension. This may partially explain why no
associations were seen in these subjects. Future studies
are required to evaluate this further. No cardiometabolic
risk factors in adolescents were associated with increased
odds of an early CVD event in a family member. How-
ever, obesity, elevated WHtR, and dyslipidemia showed
trends towards increased odds.
A number of studies have assessed the association be-
tween pediatric cardiometabolic risk factors and the
presence of cardiovascular risk factors and disease in
Table 2 Family history
Number Positive history (%)
Diabetes mellitus-1st degree 3296 291 (9 %)
Diabetes mellitus-2nd degree 3311 1457 (44 %)
Hypertension-1st degree 3229 702 (22 %)
Hypertension-2nd degree 3240 1956 (60 %)
Hyperlipidemia-1st degree 3193 618 (19 %)
Hyperlipidemia-2nd degree 3206 1670 (52 %)
Early atherosclerotic event 3467 1127 (34 %)
Fig. 1 Association between positive screening in the adolescent and odds of abnormalities in 1st and 2nd degree relatives
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family members. Morrison et al.[20] recently evaluated
the utility of risk factor screening in 5–19 year-old
school children for predicting families at high risk for
parental CVD, type 2 diabetes and high blood pressure
26 years later. They found the risk for CVD was greater
if children had high TC (relative risk (RR) 1.30) or high
low-density lipoprotein cholesterol (LDL-C) (RR 1.26) on
screening. Risk for paternal type 2 diabetes was higher in
families with pediatric high BMI (RR 1.53). Risk for par-
ental high blood pressure was higher in children who
were overweight (BMI ≥85th percentile, RR 1.23), had an
elevated LDL-C (RR 1.15), or elevated blood pressure
(RR 1.22). In addition, significant child-parent correla-
tions for TC, HDL-C, LDL-C, and glucose were ob-
served. This study concluded that identifying parents,
initiated through screening of their children (reverse cas-
cade screening), could possibly identify a cohort of young
adults where interventions could be initiated to prevent
later CVD, diabetes and hypertension. Our present study
showed that parents of adolescents with cardiometabolic
risk factors already have increased odds of silent (dyslipid-
emia and hypertension) and overt (diabetes) cardiometa-
bolic disease. Therefore, not only are family members of
children with cardiometabolic risk factors at increased risk
of developing cardiometabolic disease in the future, they
appear to be at increased risk of having cardiometabolic
disease at the time of the school-based screening.
Reis et al.[21] found that parents of children who were
obese or had an elevated waist circumference had about
6 times increased odds of having obesity or an increased
waist circumference themselves, while children who had
hypertension had 15 times increased odds of having a
parent with hypertension. These are stronger associa-
tions than those observed in our study, possibly due to
the small sample size (children and parents from 94
families) and a heterogeneous, high-risk population
(52 % of subjects were overweight or obese, 33 % had
an elevated waist circumference and 69 % were black).
A German study [22] found that children with an ele-
vated waist circumference had 2.55 times increased
odds of having a parent with increased waist circumfer-
ence, while children with elevated blood pressure did
not have increased odds of having a parent with hyper-
tension. A child with a raised non-HDL-C had 2.90
times increased odds of having a parent with an in-
creased non-HDL-C. These results are generally similar
to the findings in our study, with slightly greater odds
ratio values. However, the results of this study may not
be generalizable as it used a young (mean age 6.8 years),
solely German population with a low incidence of obes-
ity (4.5–4.9 % of children). In addition, similar to Reis
et al.[21], this study focused on child-parent correla-
tions for a given cardiometabolic risk factor, whereas
our study assessed the odds of a positive family history
of dyslipidemia, hypertension, diabetes, and premature
CVD for each identified pediatric risk factor.
Muratova et al.[23] performed nonfasting lipid screen-
ing of 709 fifth grade children, with confirmation testing
for those who screened positive. Of children with con-
firmed dyslipidemia, 66 % of their parents had confirmed
dyslipidemia. The study may not be universally applicable
as it took place in a high-risk area, with low education, low
socioeconomic status, and low levels of cholesterol screen-
ing among adults. In addition, only 36 % of the children
who screened positive had confirmatory testing due to lo-
gistical issues. Gidding et al.[24] and Polonsky et al.[25]
have both shown that children with abnormal lipid levels
have an increased incidence of having one or both parents
with a lipid disorder. Two studies have shown an increased
incidence of premature CVD in grandfathers of dyslipid-
emic children [26, 27].
Overall, our study shows similar trends to those noted
in the literature outlined above, namely that children
may be an effective proband for identifying parents and
families at risk. However, there are some novel features
and findings of the current study. First, our study was
performed within an established universal screening pro-
gram performed in a school-based setting with a large
number of subjects. Second, our study assessed a self-
reported history of established hypertension, dyslipid-
emia, and diabetes in family members, showing increased
odds of manifest cardiometabolic disease in family mem-
bers of children with cardiometabolic risk factors. Third,
this study showed that children who screened positive for
dyslipidemia had increased odds of having parents or sib-
lings with dyslipidemia, hypertension, and diabetes. Identi-
fying a raised risk profile of established cardiometabolic
disease in parents and siblings of dyslipidemic children
that is this broad is a significant finding. In addition, these
results indicate that universal pediatric lipid screening may
also identify family members with previously undiagnosed
cardiometabolic disease, thus making it a potentially ef-
fective entry into reverse cascade screening. Further stud-
ies are needed to confirm this.
Recent guidelines [11] have recommended universal
lipid screening of all pre-pubertal children between the
ages of 9–11, with the aim of early identification of both
dyslipidemia of obesity and genetic disorders of dyslipid-
emia, such as familial hypercholesterolemia (FH). This
recommendation has been met with controversy and de-
bate [28–30], with some concerns raised as to whether
the available evidence justified the recommendation. The
present study has shown a potential added benefit of
universal lipid screening that may not have been consid-
ered previously: universal school-based lipid screening,
when coupled with family history assessment, may iden-
tify risk factors clustering within families. Heterozygous
FH is relatively common, with a prevalence of at least
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1:500 in North America. If left untreated, approximately
25 % of females and 50 % of males will experience a
CVD event by the age of 50 [31]. Lipid screening in
children can potentially identify previously undetected
FH, possibly creating the conditions for an effective and
efficient public health initiative. As children typically
have parents in an age cohort that typically does not
partake in regular health-care visits, identifying children
at risk may allow for early identification and intervention
for both the child and the parents.
There are a number of limitations that should be con-
sidered when interpreting the results of this study. Given
the cross-sectional design, only associations, but not
causality, can be inferred. As data were collected within
a universal screening program, family history data was
obtained from questionnaires rather than direct detec-
tion of cardiovascular risk factors through measurement
of family members. This does not allow for the detection
of previously undiagnosed cardiometabolic risk factors
or disease in family members. Given that previous studies
have shown a large proportion of identified disease in
family members to be previously undiagnosed [23, 24],
the results of our study may be interpreted as conserva-
tive estimates of the true increased risk in family mem-
bers. However, given that the family history information
was obtained from a questionnaire, its accuracy cannot
be ensured. In future studies it will be important to per-
form direct measurements on family members in order
to detect previously undiagnosed cardiometabolic risk
factors and disease. This will allow a stronger evaluation
of the utility of universal pediatric screening as a reverse
cascade-screening tool in the detection of cardiometa-
bolic risk factors and disease in family members. Fur-
ther, the ages of the parents, siblings, and grandparents
were unfortunately not available. Ethnicity and pubertal
staging data were unavailable. Morrison et al. had previ-
ously shown that pubertal status was not a significant
explanatory variable for parental outcomes [20]. Finally,
the Heart Niagara Inc. screening program currently
screens grade 9 students. This is not in keeping with the
current expert panel guidelines [11], which suggest the
first screening in the pre-pubertal grade 5 population.
Future school-based screening studies are needed in this
younger population to help further validate the
guidelines.
Conclusions
Adolescents who have cardiometabolic risk factors, identi-
fied through universal screening, have increased odds of
having family members with diagnosed cardiometabolic
risk factors and disease. This indicates that school-based
cardiometabolic screening, along with family history as-
sessment, may identify risk factor clustering within fam-
ilies. Future studies are needed to assess the effectiveness
of screening pre-pubertal children to help validate recent
expert panel guidelines. In addition, further studies are re-
quired to establish school-based cardiometabolic screen-
ing as an effective reverse cascade-screening tool to detect
previously undiagnosed cardiometabolic disease in family
members.
Abbreviations
BMI: body mass index; CVD: cardiovascular disease; HDL-C: high-density
lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; non-HDL-
C: non-high-density lipoprotein cholesterol; OR: odds ratio; RR: relative risk;
TC: total cholesterol; WHtR: waist-to-height ratio.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MK conceived the study, interpreted the data and drafted the manuscript.
CM analyzed the data, interpreted the data and drafted the manuscript. DG
conceived the study, collected the data and interpreted the data. NC and KS
conceived the study, collected the data and interpreted the data. SD
conceived the study, interpreted the data. BWM conceived the study,
analyzed the data and interpreted the data. All authors read and approved
the final manuscript.
Acknowledgements
This work was supported by the CIBC World Markets Children’s Miracle
Foundation Chair in Child Health Research and the Canadian Institute of
Health Research Team Grant in Childhood Obesity.
Author details
1Labatt Family Heart Centre, Department of Pediatrics, The Hospital for Sick
Children, University of Toronto, 555 University Avenue, Toronto, ON M5G
1X8, Canada. 2Heart Niagara Inc., Niagara Falls, ON, Canada.
Received: 19 April 2014 Accepted: 12 January 2016
References
1. Newman 3rd WP, Freedman DS, Voors AW, Gard PD, Srinivasan SR, Cresanta JL,
et al. Relation of serum lipoprotein levels and systolic blood pressure to early
atherosclerosis. The Bogalusa heart study. N Engl J Med. 1986;314:138–44.
2. Berenson GS, Srinivasan SR, Bao W, Newman 3rd WP, Tracy RE, Wattigney
WA. Association between multiple cardiovascular risk factors and
atherosclerosis in children and young adults. The Bogalusa heart study. N
Engl J Med. 1998;338:1650–6.
3. McMahan CA, McGill HC, Gidding SS, Malcom GT, Newman WP, Tracy RE,
et al. PDAY risk score predicts advanced coronary artery atherosclerosis in
middle-aged persons as well as youth. Atherosclerosis. 2007;190:370–7.
4. McMahan CA, Gidding SS, Malcom GT, Tracy RE, Strong JP, McGill Jr
HC. Pathobiological determinants of atherosclerosis in youth risk
scores are associated with early and advanced atherosclerosis.
Pediatrics. 2006;118:1447–55.
5. Morrison JA, Friedman LA, Gray-McGuire C. Metabolic syndrome in
childhood predicts adult cardiovascular disease 25 years later: the Princeton
lipid research clinics follow-up study. Pediatrics. 2007;120:340–5.
6. Baker JL, Olsen LW, Sorensen TI. Childhood body-mass index and the risk of
coronary heart disease in adulthood. N Engl J Med. 2007;357:2329–37.
7. Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR, Berenson GS.
The relation of childhood BMI to adult adiposity: the Bogalusa heart study.
Pediatrics. 2005;115:22–7.
8. Chen W, Srinivasan SR, Elkasabany A, Berenson GS. The association of
cardiovascular risk factor clustering related to insulin resistance syndrome
(syndrome X) between young parents and their offspring: the Bogalusa
heart study. Atherosclerosis. 1999;145:197–205.
9. Chen W, Srinivasan SR, Bao W, Berenson GS. The magnitude of familial
associations of cardiovascular risk factor variables between parents and
offspring are influenced by age: the Bogalusa heart study. Ann Epidemiol.
2001;11:522–8.
Khoury et al. BMC Pediatrics  (2016) 16:11 Page 6 of 7
10. Bernstein ABHE, Moss AJ, Allen KF, Siller AB, Tiggle RB. Health care in
America: trends in utilization. National Center for Health Statistics: Hyattsville,
Maryland; 2003.
11. Expert panel on integrated guidelines for cardiovascular health and risk
reduction in children and adolescents. Summary report. Pediatrics 2011;
128(Suppl 5):S213-256.
12. McCrindle BW, Manlhiot C, Millar K, Gibson D, Stearne K, Kilty H, et al.
Population trends toward increasing cardiovascular risk factors in Canadian
adolescents. J Pediatr. 2010;157:837–43.
13. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J.
Development of a WHO growth reference for school-aged children and
adolescents. Bull World Health Organ. 2007;85:660–7.
14. McCarthy HD, Ashwell M. A study of central fatness using waist-to-height
ratios in UK children and adolescents over two decades supports the simple
message–‘keep your waist circumference to less than half your height’. Int J
Obes. 2006;30:988–92.
15. Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid
and effective global indicator for health risks of obesity and how its use
could simplify the international public health message on obesity. Int J
Food Sci Nutr. 2005;56:303–7.
16. Hsieh SD, Muto T. The superiority of waist-to-height ratio as an
anthropometric index to evaluate clustering of coronary risk factors among
non-obese men and women. Prev Med. 2005;40:216–20.
17. Khoury M, Manlhiot C, McCrindle BW. Role of the waist/height ratio in the
cardiometabolic risk assessment of children classified by body mass index. J
Am Coll Cardiol. 2013;62:742–51.
18. Khoury M, Manlhiot C, Dobbin S, Gibson D, Chahal N, Wong H, et al. Role of
waist measures in characterizing the lipid and blood pressure assessment of
adolescents classified by body mass index. Arch Pediatr Adolesc Med.
2012;166:719–24.
19. National High Blood Pressure Education Program Working Group on High
Blood Pressure in Children and Adolescents. The fourth report on the
diagnosis, evaluation, and treatment of high blood pressure in children and
adolescents. Pediatrics 2004; 114(2 Suppl):555–576.
20. Morrison JA, Glueck CJ, Wang P. The child as proband for future parental
cardiometabolic disease: the 26-year prospective Princeton lipid research
clinics follow-up study. J Pediatr. 2012;160:590–7. e593.
21. Reis EC, Kip KE, Marroquin OC, Kiesau M, Hipps Jr L, Peters RE, et al.
Screening children to identify families at increased risk for cardiovascular
disease. Pediatrics. 2006;118:e1789–97.
22. Schwandt P, Bischoff-Ferrari HA, Staehelin HB, Haas GM. Cardiovascular risk
screening in school children predicts risk in parents. Atherosclerosis. 2009;
205:626–31.
23. Muratova VN, Islam SS, Demerath EW, Minor VE, Neal WA. Cholesterol
screening among children and their parents. Prev Med. 2001;33:1–6.
24. Gidding SS, Whiteside P, Weaver S, Bookstein L, Rosenbaum D, Christoffel K.
The child as proband. High prevalence of unrecognized and untreated
hyperlipidemia in parents of hyperlipidemic children. Clin Pediatr.
1989;28:462–5.
25. Polonsky SM, Simbartl LA, Sprecher DL. Triglyceride and high-density
lipoprotein cholesterol: predicting disorders in parents from their children.
Pediatrics. 1994;94:824–31.
26. Moll PP, Sing CF, Weidman WH, Gordon H, Ellefson RD, Hodgson PA, et al.
Total cholesterol and lipoproteins in school children: prediction of coronary
heart disease in adult relatives. Circulation. 1983;67:127–34.
27. Schrott HG, Clarke WR, Wiebe DA, Connor WE, Lauer RM. Increased coronary
mortality in relatives of hypercholesterolemic school children: the Muscatine
study. Circulation. 1979;59:320–6.
28. Newman TB, Pletcher MJ, Hulley SB. Overly aggressive new guidelines for
lipid screening in children: evidence of a broken process. Pediatrics. 2012;
130:349–52.
29. McCrindle BW, Kwiterovich PO, McBride PE, Daniels SR, Kavey RE. Guidelines
for lipid screening in children and adolescents: bringing evidence to the
debate. Pediatrics. 2012;130:353–6.
30. Gillman MW, Daniels SR. Is universal pediatric lipid screening justified?
JAMA. 2012;307:259–60.
31. Kwiterovich Jr PO. Recognition and management of dyslipidemia in
children and adolescents. J Clin Endocrinol Metab. 2008;93:4200–9.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Khoury et al. BMC Pediatrics  (2016) 16:11 Page 7 of 7
